Papers matching “Summary of Product Characteristics” 28
Not finding it? Sign in to also search OpenAlex live.
-
P016 Patient Characteristics, Treatment and Long-term Outcomes from a Real-World Population of Early Breast Cancer Patients at High risk of Recurrence in Scotland2023 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
P.S. Hall, G. Tramonti, M. Rañopa, M. Vallet, R. Jarvis, W. Badreldin
1citations -
The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion2020 Frontiers in Pharmacology article Medicine Pharmaceutical Practices and Patient Outcomes Open access
Justine M. Z. van Tongeren, S. Froukje Harkes‐Idzinga, Heleen van der Sijs, Roya Atiqi, Bart J. F. van den Bemt, L.W. Draijer, +10 more
36citations -
Regulatory agencies disregard real-world effectiveness evidence on product labels beyond what is reasonable2022 Journal of Clinical Epidemiology article Pharmacology, Toxicology and Pharmaceutics Pharmaceutical industry and healthcare
Rafael Dal‐Ré, Raphaël Porcher, Frits Richard Rosendaal, Brigitte Schwarzer‐Daum
0citations -
It is time to include real-world effectiveness data on medicinal product labels2022 The Lancet Respiratory Medicine article Pharmacology, Toxicology and Pharmaceutics Pharmaceutical industry and healthcare Open access
Rafael Dal‐Ré, Raphaël Porcher, Frits R. Rosendaal, Brigitte Schwarzer‐Daum
2citations -
Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche
Guntram Buesche, H. Teoman, Rebekka K. Schneider, Flavia Ribezzo, Benjamin L. Ebert, Aristoteles A. N. Giagounidis, +7 more
4citations -
Loss of the Mechanistic Target of Rapamycin Complex 1 Causes a Lethal Alpha-1 Antitrypsin Deficiency–Associated Liver Disease2026 RWTH Publications (RWTH Aachen) article Pharmacology, Toxicology and Pharmaceutics Drug-Induced Hepatotoxicity and Protection Open access
Lisa Bewersdorf, S. Haber, Ines Volkert, Katharina Remih, Annika Groß, Christian Preisinger, +11 more
0citations -
Abstract PS3-08-14: Typer—A randomized controlled trial evaluating the effect of typology-based coaching on therapy management for patients with hr+/her2- early breast cancer under adjuvant ribociclib treatment
M.K. Welslau, Christine Zeder-Göß, Renate Haidinger, Brigitte Welter, B. Aktas, P. Wimberger, +14 more
0citations -
A Systematic Approach to Inspection Planning in Agile Process Development of Hairpin Stator Production2020 International Electric Drives Production Conference conference-paper Engineering Industrial Vision Systems and Defect Detection
Achim Kampker, Sebastian Kawollek, Patrick Treichel, Max Wendler
9citations -
Real‐world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL ( TREatment of ATopic eczema, the Netherlands) registry2023 Journal of the European Academy of Dermatology and Venereology article Medicine Dermatology and Skin Diseases Open access
Annelie H. Musters, Florine L van Lookeren, Lian F. van der Gang, M.A. Middelkamp‐Hup, Angela L. Bosma, Naomi T. Jessurun, +6 more
15citations -
Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT2026 Bone Marrow Transplantation article Medicine Multiple Myeloma Research and Treatments Open access
Nico Gagelmann, Maximilian Merz, Laurien G.A. Baaij, Linda Köster, Jorinde Desiree Hoogenboom, Joanna Ewa Drozd-Sokolowska, +7 more
1citations -
A gastruloid model of the interaction between embryonic and extra-embryonic cell types2022 Journal of Tissue Engineering article Biochemistry, Genetics and Molecular Biology Pluripotent Stem Cells Research Open access
Noémie M. L. P. Bérenger-Currias, Maria Mircea, Esmée Adegeest, Patrick R. van den Berg, Marleen Feliksik, Mazène Hochane, +3 more
26citations -
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial2023 Annals of Hematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Steffen Koschmieder, Susanne Isfort, Lutz Jacobasch, Thomas Geer, Marcel Reiser, Michael Koenigsmann, +8 more
13citations -
A systematic review on disease‐drug‐drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labelling2022 British Journal of Clinical Pharmacology review Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Laura M. de Jong, Sylvia D. Klomp, Nicoline Treijtel, Robert Rißmann, Jesse Joachim Swen, Martijn L. Manson
8citations -
Platelet‐Released Growth Factors (PRGFs) Activate NRF2‐ARE and Modulate Inflammatory Response in an NRF2‐Dependent Manner in Primary Human Keratinocytes2025 Journal of Cosmetic Dermatology article Biochemistry, Genetics and Molecular Biology Genomics, phytochemicals, and oxidative stress Open access
Mersedeh Tohidnezhad, Athanassios Fragoulis, Andreas U. Bayer, Hannes Klump, Jens Malte Baron, Thomas Pufe
2citations